Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$16.95 - $27.04 $9,780 - $15,602
577 Added 4.81%
12,580 $340,000
Q1 2024

May 10, 2024

BUY
$11.38 - $19.03 $15,829 - $26,470
1,391 Added 13.11%
12,003 $219,000
Q4 2023

Feb 09, 2024

BUY
$6.29 - $15.72 $12,674 - $31,675
2,015 Added 23.44%
10,612 $130,000
Q3 2023

Nov 13, 2023

SELL
$14.99 - $32.65 $127,444 - $277,590
-8,502 Reduced 49.72%
8,597 $128,000
Q2 2023

Aug 15, 2023

BUY
$29.76 - $46.14 $239,835 - $371,842
8,059 Added 89.15%
17,099 $555,000
Q1 2023

May 12, 2023

BUY
$38.09 - $57.79 $274,666 - $416,723
7,211 Added 394.26%
9,040 $353,000
Q4 2022

Feb 13, 2023

BUY
$40.54 - $56.2 $8,472 - $11,745
209 Added 12.9%
1,829 $96,000
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $64,899 - $86,346
-1,755 Reduced 52.0%
1,620 $73,000
Q2 2022

Aug 12, 2022

SELL
$28.03 - $45.8 $1.06 Million - $1.73 Million
-37,681 Reduced 91.78%
3,375 $123,000
Q1 2022

May 16, 2022

SELL
$29.24 - $44.06 $403,892 - $608,600
-13,813 Reduced 25.17%
41,056 $1.7 Million
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $4.94 Million - $7.74 Million
-125,637 Reduced 69.6%
54,869 $2.34 Million
Q3 2021

Nov 15, 2021

BUY
$44.0 - $65.8 $1.38 Million - $2.06 Million
31,279 Added 20.96%
180,506 $9.93 Million
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $971,444 - $1.37 Million
-21,752 Reduced 12.72%
149,227 $7.14 Million
Q1 2021

May 13, 2021

SELL
$46.31 - $62.7 $2.25 Million - $3.04 Million
-48,496 Reduced 22.1%
170,979 $8.66 Million
Q4 2020

Feb 09, 2021

BUY
$55.51 - $69.94 $18,262 - $23,010
329 Added 0.15%
219,475 $13.8 Million
Q3 2020

Nov 05, 2020

BUY
$42.19 - $69.61 $35,017 - $57,776
830 Added 0.38%
219,146 $14.7 Million
Q2 2020

Aug 13, 2020

BUY
$27.55 - $43.28 $1.19 Million - $1.86 Million
43,083 Added 24.59%
218,316 $9.15 Million
Q1 2020

May 14, 2020

BUY
$23.16 - $47.8 $4.06 Million - $8.38 Million
175,233 New
175,233 $5.52 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.